or Try an Advanced Search...

    Stage Pharmaceutical Stocks List

    Symbol Grade Name % Change
    HRMY B Harmony Biosciences Holdings, Inc. 0.83
    CASI B CASI Pharmaceuticals, Inc. -1.82
    SVRA C Savara, Inc. 15.14
    KALV C KalVista Pharmaceuticals, Inc. 0.93
    CRNX C Crinetics Pharmaceuticals, Inc. 2.86
    CRMD D CorMedix Inc -1.15
    PSTV F Plus Therapeutics, Inc. 2.04
    ITRM F Iterum Therapeutics plc -4.37
    KPTI F Karyopharm Therapeutics Inc. -6.01
    IKT F Inhibikase Therapeutics, Inc. 2.48
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Disease Cancer Clinical Medicine Medicine Multiple Myeloma Neurological Disorders Organ Systems Ovarian Cancer Treatment Of Cancer Acromegaly Advanced Solid Tumors Aging Associated Diseases Angioedema Antibody Drug Conjugate Autoimmune Disease Biotechnology Blastoma Breast And Ovarian Cancer C1 Inhibitor

    Related ETFs - A few ETFs which own one or more of the above listed Stage Pharmaceutical stocks.

    Symbol Grade Name Weight
    SBIO C ALPS Medical Breakthroughs ETF 2.99
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 1.7
    BBP B BioShares Biotechnology Products Fund 1.69
    JSML C Janus Small Cap Growth Alpha ETF 1.6
    XPH D SPDR S&P Pharmaceuticals ETF 1.54
    View all Stage Pharmaceutical ETFs...
    Compare ETFs
    Compare BBC to XPH Compare BBP to XPH Compare SBIO to BBP

        Stage Pharmaceutical Stocks Recent News

        Date Stock Title
        Jun 30 SVRA Did Savara Inc. (SVRA) Receive a Good Rating from Wall Street Analysts in Q1?
        Jun 28 SVRA Savara prices ~$100M stock offering
        Jun 28 SVRA Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
        Jun 27 KALV KalVista Initiates KONFIDENT-KID Trial for On-demand Treatment of Hereditary Angioedema Attacks with Sebetralstat in Children Aged 2 to 11
        Jun 26 CRNX Insider Sale: Chief Scientific Officer Stephen Betz Sells Shares of Crinetics Pharmaceuticals ...
        Jun 26 CASI CASI Pharmaceuticals jumps after receiving acquisition proposal for entire China business
        Jun 26 CASI CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
        Jun 26 CASI CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
        Jun 26 SVRA Savara: Today's Data 'Win' Rouses Market All Too Briefly
        Jun 26 SVRA Savara surges after late-stage trial win for lead asset against rare lung disease
        Jun 26 SVRA Savara Announces Molgramostim Nebulizer Solution (Molgramostim) Achieved Statistical Significance for Primary Endpoint and Multiple Secondary Endpoints in IMPALA-2, a Pivotal Phase 3 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
        Jun 26 SVRA Savara to Host Investor Call to Discuss Top Line Results From Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
        Jun 25 HRMY HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Disease Cancer Clinical Medicine Medicine Multiple Myeloma Neurological Disorders Organ Systems Ovarian Cancer Treatment Of Cancer Acromegaly Advanced Solid Tumors Aging Associated Diseases Angioedema Antibody Drug Conjugate Autoimmune Disease Biotechnology Blastoma Breast And Ovarian Cancer C1 Inhibitor
        Stage Pharmaceutical

        Stage Pharmaceutical is a biopharmaceutical company focused on developing innovative treatments for rare and neglected diseases. The company is developing a portfolio of novel therapies for rare and neglected diseases, including rare genetic disorders, rare cancers, and rare infectious diseases. Stage Pharmaceutical is committed to developing treatments that are safe, effective, and affordable for patients.

        Browse All Tags